When comparing the causal effect of peritoneal dialysis (PD) and hemodialysis (HD) treatment on lowering mortality in renal patients, using observational data, it is necessary to adjust for different forms of confounding and informative censoring. Both the type of dialysis treatment that is started with and mortality are affected by baseline covariates. Longitudinal and baseline variables can affect both the probability of switching from one type of dialysis to the other, and mortality. Longitudinal and baseline variables can also affect the probability of receiving a kidney transplant, possibly causing informative censoring. Adjusting for longitudinal variables by including them as covariates in a regression model potentially causes bias, for instance by losing a possible indirect effect of dialysis on mortality via these longitudinal variables. Instead, we fitted a marginal structural model (MSM) to estimate the causal effect of dialysis type, adjusted for confounding and informative censoring. We used the MSM to compare the hazard of death as well as cumulative survival between the potential treatment trajectories "always PD" and "always HD" over time, conditional on age and diabetes mellitus status. We used inverse probability weighting (IPW) to fit the MSM.
INTRODUCTION
In a previous study by Termorshuizen et al. (2003) , mortality rates for renal patients undergoing hemodialysis (HD) were compared with mortality rates for renal patients undergoing peritoneal dialysis (PD). Termorshuizen et al. analyzed mortality data according to dialysis type at baseline, adjusting for baseline covariates using a Cox regression model. In the present study, we fitted a marginal structural model (MSM) to compare the causal hazard of death as well as cumulative survival between receiving PD or HD from the start of dialyses treatment, respectively. We used the same data as used by Termorshuizen et al., but with longer follow-up and more patients included. In the MSM, adjusted for baseline covariates as was done in the analysis performed by Termorshuizen et al. In addition, by using a MSM we were able to address the following methodological issues:
1. Patients who started on a certain treatment modality (PD or HD) could switch to the other modality during the course of dialysis treatment. The probability of switching may depend on baseline and time varying covariates (Fenton et al., 1997; Schaubel et al., 1998) . When censoring patients at the moment of switching, as we did in our analysis, this censoring is informative.
2. Patients were censored when they received a kidney transplant. The placement of patients on the transplant waiting list depended on baseline and time varying covariates which could affect mortality. This could cause informative censoring.
From 1) and 2) it is clear that, when investigating the effect of dialysis treatment on mortality, it is necessary not only to adjust for baseline variables, but also for longitudinal variables. This could be done by conditioning, including the variables in a model for the effect of treatment on mortality. However, that would induce bias when the time varying covariates that are adjusted for are intermediate for at least part of the effect of dialysis. The effect of dialysis via those time varying covariates would then be lost. Moreover, estimates from such conditional models are in general not equal to marginal causal effect estimates due to non-collapsibility (Greenland et al., 1999) . Also, when there exists an unmeasured variable that affects both a time varying covariate that is conditioned on, as well as mortality, selection bias will arise. This is a form of Berkson's bias (Berkson, 1946) . MSMs do not suffer from these drawbacks (Robins, , 1998 Robins et al., 2000; Hernán et al., 2000; Cole et al., 2003; Hernán & Robins, 2006; Cole & Hernán, 2008) .
We used inverse probability weighting (IPW) (Cole & Hernán, 2008) to fit a MSM, using separate weightings to adjust for:
1. The effect of baseline covariates on the choice of treatment modality at the start of dialysis treatment.
2. The effect of baseline and time varying covariates on treatment switching, both from PD to HD and vice versa.
3. Informative censoring caused by baseline and time varying covariates (including dialysis treatment), that affect the probability of receiving a kidney transplant.
It is likely that the hazard ratio between HD and PD is non-proportional over time, and that there is interaction of the effect of dialysis with both age and diabetes mellitus status (Held et al., 1994; Collins et al., 1999; Nelson et al., 1992; Bloembergen et al., 1995; Vonesh & Moran, 1999; Winkelmayer et al., 2002) . Therefore, we fitted a MSM to compare mortality between PD and HD over time since the start of dialysis treatment, conditional on age and diabetes mellitus status. From this model we calculated both hazard ratios and cumulative survival at specific time points, for specific values of age and diabetes mellitus status, to quantify the causal effect of interest.
DATA
We used data from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) (Boeschoten, 2003) . From 1996 up to 2006, patients with end stage renal disease were included at the start of dialysis treatment. Measurements were taken at baseline and subsequently every 6 months, with an extra measurement at 3 months. We selected only patients who survived the first 3 months of dialysis, to avoid problems associated with early events due to acute renal failure. The total number of patients selected for the analysis was 1800, including 382 (21.2%) diagnosed with diabetes mellitus. Follow-up ended at death, censoring or dialysis treatment switching. Average followup length was 2.5 years. At baseline 609 patients started on PD and 1191 patients started on HD. Of those patients who started on PD, 143 (23.5%) switched to HD over time. Of those patients who started on HD, 64 (5.4%) switched to PD. Temp orary switches, i.e. switches back to the original treatment within 3 months, were ignored. Switches less than 3 months before death were also ignored. Within follow-up 686 deaths and 431 kidney transplants were observed. Table 1 contains an overview of the variables that were used in the analysis. Time varying covariates were all measured from the start of dialysis onwards, except for nutritional status which was measured from 3 months onwards. Nutritional status at three months was therefore taken as "baseline" nutritional status.
METHOD

Data preparation
We used the following data structure. For each individual i, the data matrix contained rows j = 0, . . . , n i − 1, which corresponded to time points from baseline up to the individual end time, spaced 10 days apart 1 . Subjects were represented by the set
The most recent time varying covariate measurements taken before time point j were contained in L ij . We indicated treatment modality at time point j with A ij (A = 0 for PD, A = 1 for HD). We indicated the observed death status at time point j with Y ij (0 = alive, 1 = died), and the receiving of a kidney transplant at time point j with Z ij (0 = no transplant, 1 = transplant). Measurement times, observed death times and the times at which a kidney transplant was received were rounded to 10 days to facilitate the construction of the data frame. At time point j, L ij was measured before A ij , which was measured before Y ij and Z ij . The baseline covariates were contained in V i , not including the baseline measurements of the time varying covariates, which were contained in L i0 .
The individual end time was determined as the minimum of the time of death, the time of the last measurement and the time of switching from one type of dialysis to the other. Individuals were censored after switching because we were interested in comparing the hazard of death for the treatment histories "always PD" and "always HD" only.
We used last value carried forward imputation for the time varying covariates in L, instead of a more elaborate model based imputation, since: 1) extrapolation had to be done over 6 months at maximum, which is a short period relative to the variability of the measurements; 2) we did not want to smooth the longitudinal measurements, assuming it were the measured values of L that affected dialysis treatment and the receiving of a kidney transplant.
IPW adjustment for the effect of baseline covariates on the starting treatment
To adjust for the effect of the baseline covariates contained in V and L 0 on the choice of treatment modality at baseline, A 0 , we used IPW as in a pointtreatment study (Robins, 1998; Robins et al., 2000) . We estimated the weights
The numerator of (1) contains the marginal probability of starting on the observed treatment modality, a i0 , which is simply the proportion of subjects who started on the same treatment modality as subject i. The denominator of (1) contains the probability of starting on the observed treatment modality a i0 given an individual's observed baseline covariate values l i0 and v i . Weighting individuals i by
would result in adjusting for the effect of baseline covariates on treatment modality at the start of dialysis treatment. Covariates L 0 and V do not predict the starting dialysis type in the dataset weighted by w i . Including the probability P [A i0 = a i0 ] in the numerator, as is done in (1), "stabilizes" the weights, increasing efficiency (Robins, 1998) . The denominator of (1) was estimated using the logistic model
regressing the probability of starting on HD on the baseline covariates, with parameters α. The specific form of f 1 will be clarified below. For individuals who actually started on HD, the denominator of (1) was then computed as
For individuals who actually started on PD, the denominator of (1) was computed as 1
IPW adjustment for the effect of baseline and time varying covariates on treatment switching
We used IPW to adjust for the effect of baseline and time varying covariates on the probability of switching from PD to HD in the following manner, similar to Hernán et al. (2000) . The rows ij of the data matrix were weighted by sw † ij . For patients who started on HD, and therefore could not switch from PD to HD, sw † ij = 1 always. For patients who started on PD, we estimated the stabilized weights
(3) is a product over all previous time points after baseline up to the time point j. Since switching was not possible at baseline, sw † i0 = 1 always. The factors in the numerator of (3) contain the probability of the observed treatment modality at each time point a ik (either HD or PD), given the observed treatment history up to the previous time pointā ik−1 (which was "always PD" for patients starting on PD, before switching). The factors in the denominator of (3) contain the probability of the observed treatment modality at each time point, given the observed treatment history up to the previous time point, the observed longitudinal covariate historyl ik , and the observed baseline covariates v i . The factors in the denominator of (3) were estimated using the model (4) with parameters β. We assumed that the effect of the time varying covariate history¯L(j), was fully expressed via the last value L(j). This model was fitted on time points after baseline for patients who started on PD. The specific form of f 2 will be clarified below. When a patient had not yet switched from PD to HD, the factor in (3) corresponding to time point k was computed
, using (4). At the time point of switching from PD to HD the factor in (3) was computed as
The factors in the numerator were estimated analogously, using a model similar to (4), but not including L and V . In an analogous way, we estimated weights sw ‡ ij to correct for the effect of time varying and baseline covariates on the probability of switching from HD to PD.
IPW adjustment for informative censoring due to the receiving of a kidney transplant
Similar to the correction for informative censoring used in Hernán et al. (2000) , we adjusted for the effect of baseline and time varying covariates as well as treatment modality on the probability of receiving a kidney transplant, by weighting the rows ij of the data matrix by the stabilized weights
The factors in the numerator of (5) contain the probability of the observed transplant status at each time point, z ik , given the observed transplant status 2 We used the cloglog model as an approximation of a Cox model.
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The factors in the denominator of (5) contain the probability of the observed transplant status at each time point, given the observed transplant status history up to the previous time point, the observed treatment history up to the present time point, the observed time varying covariate history up to the present time point and observed baseline covariates. These factors were estimated analogously to the estimation of the factors in (3), using for the denominator the model
with parameters γ. We assumed that the effects of the time varying covariate history¯L(j) and the treatment history¯A(j) were fully expressed via L(j) and A(j), respectively. To estimate the numerator of (5) we used a model similar to (6) but not including A, L and V . The specific form of f 3 will be clarified below.
3.5 Construction of models (2), (4) and (6) The models that were used to estimate the denominators of the weights sw 0 i , sw † ij , sw ‡ ij and sw ij , as described in the previous sections, were constructed as follows. First we included main effects of all baseline and time varying covariates. Follow-up time was also included, except in model (2). To account for possible non-linearity, we fitted natural splines with 5 degrees of freedom on follow-up time. A main effect of dialysis treatment was included in model (6), as a potential predictor of receiving a kidney transplant. We then selected relevant predictors using backward model selection, removing terms when that would improve Akaike's information criterion (AIC), but always keeping follow-up time in the models. After this first step, we added two-way interactions between all terms except with follow-up time, which would lead to an unfeasible number of parameters. We then performed AIC-based backward model selection again, always keeping follow-up time in the models. We wanted to keep follow-up time in models (4) and (6), as approximations of the respective baseline hazards. Note that we entered Davies score as a continuous variable, as was done in Fried et al. (2003) .
Causal model and inference
To compare the hazard of death for PD and HD over time, conditional on diabetes mellitus and age, we fitted the conditional causal model
with V 1 age at baseline, V 2 diabetes mellitus status at baseline, g 1 (j) = 1, g 2 (j) = j and g 3 (j) = j 2 . With T the time of death, the subscript T a 0 indicates that we compared mortality between the different "counterfactual" scenarios in which the study population would have received a longitudinal exposure history that does not include a treatment switch. We estimated the causal hazard ratio comparing mortality between the exposure histories "always PD" and "always HD" (a 0 = 0 and a 0 = 1, respectively). As indicated in (7), we estimated a time-varying hazard ratio, conditional on age and diabetes mellitus. Note that if we were investigating the hazard over time for all possible longitudinal exposure histories, most of which do include a treatment switch, the hazard of death at each time point would possibly be affected by the previous exposure history. For instance, the hazard ratio between PD and HD might depend on the amount of time already spent on both HD and PD. Model (7) was fitted on our dataset, with elements ij weighted by the product sw
This weighting removed the effect of baseline covariates on the choice of treatment modality at the start of dialysis treatment, the effect of baseline and longitudinal variables on treatment modality switching, and the effect of baseline and longitudinal variables as well as dialysis treatment, on the probability of receiving a kidney transplant. We assumed that there was no additional unmeasured confounding and informative censoring, that (2), (4) and (6) had been correctly specified and that the population values of the probabilities estimated in the denominators of (1), (3) and (5) were always larger than 0, which is the assumption of experimental treatment assignment (ETA) (Cole & Hernán, 2008) . It is also necessary to make the consistency assumption, which states that an individual's potential outcome under his or her observed exposure history is precisely her observed outcome. Making this latter assumption is reasonable when estimating the effect of a medical treatment (Cole & Hernán, 2008) . The causal effect of dialysis treatment on mortality can then be estimated unbiasedly by fitting a MSM on the weighted dataset Hernán et al., 2000) . To investigate the effect of weighting, we also fitted a model similar to (7) on our dataset, but without weighting.
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The International Journal of Biostatistics, Vol. 6 [2010] , Iss. 1, Art. 2 DOI: 10.2202 /1557 -4679.1166 We specified MSM (7) a priori and included all main effects, two-way and tree-way interactions between dialysis treatment, age and diabetes status. We included interactions with the time functions g m (j) to allow for time varying effects. From (7) we then computed hazard ratios comparing mortality on HD versus PD, for specific values of age and diabetes status, at different time points since the start of dialysis treatment to quantify the causal effect of interest. After computing a Breslow estimate of the cumulative baseline hazard λ 0 (j), we used (7) to predict survival over time for patients starting and staying on PD or HD, respectively.
Confidence intervals for estimated hazard ratios and predicted survival were constructed using the bootstrap. Patients were resampled with replacement, after which model construction as outlined in section 3.5 was performed, the inverse probability weights were computed and (7) was fitted on the resampled dataset. Bias-corrected confidence intervals (Efron & Tibshirani, 1993) were then computed using 1500 bootstrap samples. Therefore, the uncertainty introduced by estimating the inverse probability weights and by performing AIC-based stepwise model selection were taken into account in the confidence intervals. Table 2 contains an overview of included terms, with parameter estimates, standard errors and significance, for the models used to estimate the inverse probability weights. We do not show intercepts and follow-up time, in order to be concise. These models include a fairly large number of terms, except the model for prediction of the switch from HD to PD, which includes only age and malignancy.
RESULTS
The distributions of the inverse probability weights, which were estimated as described above, are summarized in Table 3 . According to Cole & Hernán (2008) , desirable properties for the distribution of stabilized weights are: 1) a mean close to 1 and 2) a relatively small range. A weights distribution with a mean different from 1 could be an indication of model misspecification and/or violation of the ETA assumption, which could both lead to bias of the causal effect estimate. A relatively narrow weights distribution is beneficial for the efficiency of effect estimates. For time varying weights these conditions should be met at each time point. As an approximation of describing the distribution of weights at each time point, we pooled time varying weights together within each year since the start of dialysis treatment. Both of the conditions are met, regarding the distributions of the weights sw 0 i , sw † ij , sw ‡ ij and sw ij as well as Table 2 : Parameter estimates, standard errors and significance levels for models used to compute the inverse probability weights. Continuous variables were standardized at the mean (mean at baseline for time varying variables). Figure 1: Predicted survival depending on dialysis type and age, without diabetes mellitus, computed from causal model (7), adjusted using IPW for baseline and time varying covariates listed in Table 1. the distribution of the combined weights sw
The combined weights are similarly distributed as the stabilized weights estimated by Hernán et al. (2000) .
To facilitate interpretation of the parameters of causal model (7) we computed hazard ratios comparing survival for HD versus PD, at 3, 12, 24 and 36 months since the start of dialysis, for ages of 40, 50, 60, 65, 70 and 75 years, both with and without diabetes mellitus (Table 4 ). The chosen ages reflect approximately equal percentiles of the age distribution in our sample. We computed the same hazard ratios from a model similar to (7), but without weighting (Table 5) .
As seen in Table 4 , without diabetes, the causal hazard of death for HD seems to be always higher than for PD at 3 months, although this difference is never significant. This difference seems to be larger for younger patients. After the first 3 months, the causal hazard of death for HD seems to become lower than for PD, often significantly. For older patients it takes longer for
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The International Journal of Biostatistics, Vol. 6 [2010] Figure 2: Predicted survival depending on dialysis type and age, with diabetes mellitus, computed from causal model (7), adjusted using IPW for baseline and time varying covariates listed in Table 1. this difference to occur. With diabetes and for ages of 60 and younger, the causal hazard of death for HD seems to be always higher than for PD at 3 and 12 months, although not significantly (Table 4) . For older patients, the causal hazards of death for HD and PD seem to be quite similar at 3 and 12 months. After the first 12 months, the causal hazard of death for HD seems to become lower than for PD, especially in younger patients, although never significantly.
As seen in Table 5 , without weighting we find a larger, always significant difference in hazard in favour of PD at 3 months in patients without diabetes. A smaller difference, still in favour of PD, is also detected at 12 months. After the first 12 months the hazards for PD and HD seem to be almost equal for patients without diabetes. We see a similar pattern for patients with diabetes; without weighting we detect hazard ratios which are in general more in favour of PD.
Figures 1 and 2 depict survival for HD and PD as predicted from causal model (7), for varying age, without and with diabetes respectively. For clarity we do not show confidence intervals, which are largely overlapping. During the initial period of 3 to 12 months, the apparently higher hazard of death for HD for ages of 60 and younger does not result in substantially lower predicted survival for HD. The apparent contrast between the size of this small absolute survival difference and the hazard ratios in Table 4 is due to a low baseline hazard of death. For all ages, with or without diabetes, our results seem to indicate equal survival during an initial period of 24 to 36 months, after which survival for PD seems to gradually become lower than for HD, although not significantly in this study. It is also apparent that survival is lower for higher ages, and for patients with diabetes.
DISCUSSION
We used IPW to estimate the parameters of a MSM, adjusting for the effects of baseline and time varying covariates on dialysis treatment and receiving a kidney transplant. These adjustments could not be made using standard conditioning, since that could lead to adjusting away the effect of treatment, inducing Berkson's bias and inducing non-collapsibility. Making these adjustments was necessary, as can be inferred from the fact that estimates from an unweighted model differed substantially from estimates from the MSM. This study is the first to use IPW to make these adjustments when comparing mortality in renal patients on PD and HD. Under the assumptions noted in section 3, our results are comparable to results from a hypothetical trial in which dialysis treatment was randomized at the start and followed throughout follow-up, and in which no informative censoring was present. The causal effect of interest, the difference in mortality between PD and HD over time since the start of dialysis treatment, conditional on age and diabetes mellitus status, was quantified in two ways. First we computed hazard ratios from causal model (7). Second, we computed cumulative survival from (7). Both can be interpreted as causal effect estimates, describing mortality in the population under the two potential treatment histories of interest, "always PD" and "always HD". Note that we estimated the baseline hazard in (7) using the weighted dataset, in order to compute cumulative survival. This baseline hazard is an unbiased estimate of the baseline hazard in the population, assuming that there is no unmeasured confounding and informative censoring in the weighted dataset. Our estimates of cumulative survival are comparable to the adjusted survival curves with inverse probability weights used by Cole & Hernán (2004) .
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The International Journal of Biostatistics, Vol. 6 [2010] , Iss. 1, Art. 2 DOI: 10.2202 /1557 -4679.1166 Point estimates of hazard ratios from our MSM, comparing the hazard of death for PD and HD over time and conditional on age and diabetes mellitus, differed systematically from 1, although in general not significantly. In younger patients, both with and without diabetes, the hazard of death was lower for PD during an initial period of 3 to 12 months. After this initial period, the hazard became higher for PD. In older patients, we found more similar hazards of death for HD and PD. Estimated survival was similar for HD and PD during an initial period of 12 to 36 months, after which survival declined more rapidly for PD. This suggests that there is a difference in mortality between PD and HD. However, replication of this study is recommended, preferably using a larger dataset.
